Comments on: EKR Therapeutics and the sweet taste of “re-acquisition” http://venturebeat.com/2008/02/06/ekr-therapeutics-and-the-sweet-revenge-of-re-acquisition/ News About Tech, Money and Innovation Tue, 24 Nov 2009 22:13:15 +0000 http://wordpress.org/?v=2.8.5 hourly 1 By: HArry http://venturebeat.com/2008/02/06/ekr-therapeutics-and-the-sweet-revenge-of-re-acquisition/comment-page-1/#comment-864189 HArry Thu, 26 Jun 2008 17:53:40 +0000 http://venturebeat.com/2008/02/06/ekr-therapeutics-and-the-sweet-revenge-of-re-acquisition/#comment-864189 File File

]]> By: Life-science briefing: Monday, March 10, 2008 » VentureBeat http://venturebeat.com/2008/02/06/ekr-therapeutics-and-the-sweet-revenge-of-re-acquisition/comment-page-1/#comment-798300 Life-science briefing: Monday, March 10, 2008 » VentureBeat Mon, 10 Mar 2008 14:50:04 +0000 http://venturebeat.com/2008/02/06/ekr-therapeutics-and-the-sweet-revenge-of-re-acquisition/#comment-798300 [...] ESP Pharmaceuticals handed to PDL in a 2005 acquisition, an interesting turn of events we covered here. Tags: biotechnology, co:BrainCells, co:EKR-Therapeutics, deal, inv:Bay-City-Capital, [...] [...] ESP Pharmaceuticals handed to PDL in a 2005 acquisition, an interesting turn of events we covered here. Tags: biotechnology, co:BrainCells, co:EKR-Therapeutics, deal, inv:Bay-City-Capital, [...]

]]>